| LVAD | Control | |
| Bleeding | 41% (31) | 0% |
| Infection | 41% (31) | 15% (5) |
| Thromboembolism | ||
| 4% (3) | 0% | |
| RV failure | 15% (11) | 3% (1) |
| Hemolysis | 8% (6) | 3% (1) |
| Septic embolism 3% | 0% | |
| Renal dysfunction | ||
| 53% (40) | 61% (20) NS | |
| LVAD | Control | |
| Bleeding | 41% (31) | 0% |
| Infection | 41% (31) | 15% (5) |
| Thromboembolism | ||
| 4% (3) | 0% | |
| RV failure | 15% (11) | 3% (1) |
| Hemolysis | 8% (6) | 3% (1) |
| Septic embolism 3% | 0% | |
| Renal dysfunction | ||
| 53% (40) | 61% (20) NS | |